CME Group Inc. (NASDAQ:CME)‘s stock had its “hold” rating reiterated by equities research analysts at Keefe, Bruyette & Woods in a research note issued to investors on Thursday. They currently have a $133.00 target price on the financial services provider’s stock. Keefe, Bruyette & Woods’ target price would suggest a potential downside of 0.60% from the company’s current price.

CME has been the subject of a number of other research reports. Jefferies Group LLC reissued a “buy” rating and issued a $134.00 price objective (up previously from $128.00) on shares of CME Group in a research note on Monday, July 17th. Barclays PLC assumed coverage on shares of CME Group in a research note on Friday, September 8th. They issued an “overweight” rating and a $139.00 price objective for the company. Royal Bank Of Canada set a $130.00 price target on shares of CME Group and gave the stock a “buy” rating in a report on Monday, June 12th. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Finally, UBS AG reaffirmed a “buy” rating and issued a $135.00 price target (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $133.22.

Shares of CME Group (CME) opened at 133.80 on Thursday. The stock has a market cap of $45.48 billion, a P/E ratio of 27.31 and a beta of 0.72. CME Group has a 1-year low of $98.95 and a 1-year high of $134.24. The company has a 50 day moving average price of $126.73 and a 200 day moving average price of $122.14.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. The company had revenue of $925.00 million during the quarter, compared to the consensus estimate of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. CME Group’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.14 earnings per share. On average, equities analysts anticipate that CME Group will post $4.82 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc. (CME) Given Hold Rating at Keefe, Bruyette & Woods” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2017/09/21/cme-group-inc-cme-given-hold-rating-at-keefe-bruyette-woods.html.

In other news, Director Martin J. Gepsman sold 200 shares of the business’s stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $126.14, for a total transaction of $25,228.00. Following the sale, the director now directly owns 43,311 shares of the company’s stock, valued at $5,463,249.54. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Terrence A. Duffy sold 21,815 shares of the business’s stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the sale, the chairman now directly owns 110,711 shares in the company, valued at $13,715,985.79. The disclosure for this sale can be found here. Insiders have sold 48,244 shares of company stock worth $6,021,890 over the last three months. Corporate insiders own 0.57% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Fiduciary Trust Co. purchased a new stake in shares of CME Group during the second quarter valued at $105,000. Quadrant Capital Group LLC grew its holdings in shares of CME Group by 13.6% during the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after buying an additional 113 shares during the last quarter. Parallel Advisors LLC grew its holdings in shares of CME Group by 4.1% during the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after buying an additional 43 shares during the last quarter. San Francisco Sentry Investment Group CA purchased a new stake in shares of CME Group during the second quarter valued at $129,000. Finally, Whittier Trust Co. grew its holdings in shares of CME Group by 2.6% during the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after buying an additional 27 shares during the last quarter. 82.64% of the stock is currently owned by hedge funds and other institutional investors.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.